MedTrace Logo

Emollients in the Management of Atopic Dermatitis

NCT01779258 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 347

Last updated 2014-02-19

No results posted yet for this study

Summary

The purpose of this study is to confirm that emollients play a major role in the maintenance therapy after clearing of inflammatory lesions and can reduce occurrence of flares in children with atopic dermatitis.

Conditions

Interventions

DRUG

glycerol, paraffin (liquid and white soft)

1 application in the morning and in the evening

DEVICE

Atopiclair®

1 application in the morning, in the afternoon and in the evening

DRUG

Locatop@

During the Run-In period: 1 application in the morning and in the evening during a maximum of 21 days

DRUG

Locapred@

During the 3 months study treatment: 1 application in the evening in case of flare "

Sponsors & Collaborators

  • Pierre Fabre Medicament

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Estonia
  • France
  • Lithuania
  • Poland
  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01779258 on ClinicalTrials.gov